| Literature DB >> 34508122 |
Prapat Suriyaphol1, Jimmy Ka Ho Chiu2, Nathamon Yimpring3, Paiboon Tunsagool4, Wuttichai Mhuantong5, Rungtip Chuanchuen6, Irina Bessarab7, Rohan B H Williams7, Rick Twee-Hee Ong8, Gunnaporn Suriyaphol9.
Abstract
This study aimed to characterize the alteration of the fecal microbiome and antimicrobial resistance (AMR) determinants in 24 piglets at day 3 pre-weaning (D. - 3), weaning day (D.0), days 3 (D.3) and 8 post-weaning (D.8), using whole-genome shotgun sequencing. Distinct clusters of microbiomes and AMR determinants were observed at D.8 when Prevotella (20.9%) was the major genus, whereas at D. - 3-D.3, Alistipes (6.9-12.7%) and Bacteroides (5.2-8.5%) were the major genera. Lactobacillus and Escherichia were notably observed at D. - 3 (1.2%) and D. - 3-D.3 (0.2-0.4%), respectively. For AMR, a distinct cluster of AMR determinants was observed at D.8, mainly conferring resistance to macrolide-lincosamide-streptogramin (mefA), β-lactam (cfxA6 and aci1) and phenicol (rlmN). In contrast, at D. - 3-D.3, a high abundance of determinants with aminoglycoside (AMG) (sat, aac(6')-aph(2''), aadA and acrF), β-lactam (fus-1, cepA and mrdA), multidrug resistance (MDR) (gadW, mdtE, emrA, evgS, tolC and mdtB), phenicol (catB4 and cmlA4), and sulfonamide patterns (sul3) was observed. Canonical correlation analysis (CCA) plot associated Escherichia coli with aac(6')-aph(2''), emrA, mdtB, catB4 and cmlA4 at D. - 3, D.0 and/or D.3 whereas at D.8 associations between Prevotella and mefA, cfxA6 and aci1 were identified. The weaning age and diet factor played an important role in the microbial community composition.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34508122 PMCID: PMC8433359 DOI: 10.1038/s41598-021-97586-9
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Stacked bar plot showing taxonomic relative abundance distribution of fecal microbial communities at the phylum level of piglets, with samples sub-categorized by maternal litter and age at day 3 pre-weaning (D. − 3), weaning day (D.0), days 3 (D.3) and 8 post-weaning (D.8).
The relative abundance of phyla in piglets at day 3 pre-weaning (D. − 3), weaning day (D.0), days 3 (D.3) and 8 post-weaning (D.8).
| Phyla | Relative frequency (%) ± SD | |||
|---|---|---|---|---|
| D. − 3 | D.0 | D.3 | D.8 | |
| 46.01 ± 13.60ab | 37.88 ± 12.72ac | 31.72 ± 11.22c | 49.73 ± 14.34b | |
| 35.38 ± 13.77ab | 40.37 ± 11.77ac | 47.20 ± 8.90c | 30.46 ± 10.60b | |
| 3.63 ± 3.60a | 3.08 ± 1.73a | 3.12 ± 2.23a | 1.54 ± 1.12b | |
| 1.22 ± 2.52ab | 0.47 ± 0.77a | 0.98 ± 1.02b | 0.21 ± 0.55c | |
| 0.62 ± 0.97a | 2.16 ± 2.66b | 1.54 ± 1.70b | 3.07 ± 2.12c | |
| 0.57 ± 1.28ab | 0.61 ± 1.39a | 0.06 ± 0.06a | 0.03 ± 0.04b | |
| 0.25 ± 0.23a | 0.40 ± 0.49a | 0.34 ± 0.43a | 0.58 ± 0.33b | |
| 0.24 ± 0.22a | 0.44 ± 0.83a | 0.19 ± 0.15a | 0.04 ± 0.05b | |
| 0.19 ± 0.15a | 0.32 ± 0.42a | 0.27 ± 0.22b | 0.20 ± 0.07a | |
| Others | 0.18 ± 0.02a | 0.22 ± 0.02ab | 0.24 ± 0.02ab | 0.34 ± 0.08b |
| Unclassified phylum | 11.52 ± 2.90a | 13.85 ± 3.06b | 14.16 ± 3.11b | 13.52 ± 2.10b |
| Unknown | 0.20 ± 0.07a | 0.18 ± 0.06a | 0.18 ± 0.06a | 0.26 ± 0.05b |
a,b,cA significant difference in the same row at P < 0.05.
Figure 2Principal coordinates analysis (PCoA) plot of antimicrobial resistance determinants obtained from piglets at day 3 pre-weaning (D. − 3), weaning day (D.0), days 3 (D.3) and 8 post-weaning (D.8). The oval shows a D.8 sample group that is separated from. D. − 3–D.3 groups. Taxonomic abundance (A). AMR gene abundance (B). Beta diversity group significance: P value = 0.001, PERMANOVA, 999 permutations.
Adonis results for gut microbiome in piglets from day 3 pre-weaning to day 8 post-weaning.
| Groups | R2-distances | |
|---|---|---|
| Weaning age and diet | 0.243 | 0.001 |
| Litter | 0.035 | 0.058 |
| Piglet | 0.187 | 0.998 |
Relative abundances of the 10 most abundant genera in each piglet group at day 3 pre-weaning (D. − 3), weaning day (D.0), days 3 (D.3) and 8 post-weaning (D.8).
| Taxonomy | Relative frequency (%) ± SD | |||
|---|---|---|---|---|
| D. − 3 | D.0 | D.3 | D.8 | |
| 12.69 ± 9.99a | 6.86 ± 4.90ab | 7.04 ± 7.30b | 6.01 ± 6.13b | |
| 8.54 ± 6.66a | 8.23 ± 5.68a | 5.22 ± 2.97a | 2.73 ± 0.79b | |
| 7.18 ± 7.32a | 6.96 ± 6.31a | 3.63 ± 2.00a | 20.88 ± 11.28b | |
| 4.68 ± 4.51ab | 7.98 ± 5.38a | 6.84 ± 5.05a | 2.84 ± 2.21b | |
| 1.20 ± 0.70a | 1.20 ± 0.80a | 2.73 ± 3.08b | 0.37 ± 0.55c | |
| 1.17 ± 1.69a | 0.22 ± 0.18b | 0.34 ± 0.44b | 0.96 ± 2.04ab | |
| 0.84 ± 0.91a | 0.48 ± 0.44ab | 0.34 ± 0.30b | 0.63 ± 0.33a | |
| 0.83 ± 2.48a | 0.25 ± 0.73a | 0.13 ± 0.13a | 0.02 ± 0.05b | |
| 0.81 ± 0.65ab | 1.17 ± 1.40a | 0.43 ± 0.33b | 0.10 ± 0.08c | |
| 0.57 ± 0.42a | 0.73 ± 1.01a | 0.26 ± 0.23b | 0.61 ± 0.27a | |
| 0.49 ± 0.78a | 1.67 ± 2.42b | 1.16 ± 1.32ab | 2.64 ± 1.95c | |
| 0.48 ± 1.07ab | 0.49 ± 1.09a | 0.04 ± 0.05a | 0.02 ± 0.04b | |
| 0.47 ± 0.33a | 0.66 ± 0.39ab | 0.54 ± 0.20a | 0.82 ± 0.33b | |
| 0.37 ± 0.24a | 0.33 ± 0.17a | 0.55 ± 0.34a | 0.10 ± 0.08b | |
| 0.23 ± 0.28a | 0.26 ± 0.18ab | 0.43 ± 0.48b | 0.61 ± 0.36c | |
a,b,cA significant difference in the same row at P < 0.05.
Percent of fragments per kilobase of exon model per million reads mapped (FPKM) of antimicrobial drug resistance patterns in piglets at day 3 pre-weaning (D. − 3), weaning day (D.0), days 3 (D.3) and 8 post-weaning (D.8).
| Antimicrobial drug resistance patterns | Relative frequency (%) ± SD | |||
|---|---|---|---|---|
| D. − 3 | D.0 | D.3 | D.8 | |
| Aminoglycosides | 33.33 ± 7.07a | 36.37 ± 7.71ab | 39.47 ± 5.48b | 25.56 ± 7.46c |
| Tetracyclines | 29.89 ± 7.03ab | 28.77 ± 4.39 ab | 28.74 ± 6.37a | 30.94 ± 2.53b |
| Macrolide-Lincosamide-Streptogramin (MLS) | 19.97 ± 4.28a | 20.77 ± 4.64a | 19.61 ± 4.21a | 30.12 ± 6.02b |
| Multidrug resistance (MDR) | 5.58 ± 5.54a | 3.86 ± 3.45a | 3.76 ± 4.15a | 0.84 ± 1.37b |
| β-lactams | 4.22 ± 2.71a | 4.32 ± 2.44a | 2.37 ± 1.05b | 6.31 ± 2.73c |
| Phenicols | 3.33 ± 1.88a | 3.36 ± 1.29a | 3.73 ± 1.49a | 5.05 ± 1.65b |
| Sulfonamides | 0.57 ± 0.56a | 0.46 ± 0.47ab | 0.23 ± 0.24b | 0.07 ± 0.21c |
| Others | 3.10 ± 1.82 | 2.09 ± 0.96 | 2.09 ± 1.21 | 1.11 ± 0.76 |
a,b,cA significant difference in the same row at P < 0.05.
Figure 3Canonical correlation analysis (CCA) plot showing the distribution of piglets at day 3 pre-weaning (D. − 3), weaning day (D.0), days 3 (D.3) and 8 post-weaning (D.8). Microbiome genera and antimicrobial resistance (AMR) genes according to corresponding antimicrobial drug resistance patterns. CCA plot showing inter-relationships between taxon abundance profiles and AMR sequences over all 96 samples (A). CCA plot of AMR genes corresponding to aminoglycoside drug resistance pattern (B). CCA plot of AMR genes corresponding to multidrug resistance pattern (C). CCA plot of AMR genes corresponding to phenicol drug resistance patterns (D). CCA plot of AMR genes corresponding to macrolide, lincosamide and streptogramin resistance (MLS) patterns (E). CCA plot of AMR genes corresponding to β-lactam resistance patterns (F). Blue circles indicate high abundant genes correlated with Escherichia or Prevotella. Red circles indicate Escherichia (G13) and Prevotella (G26). AMR genes (A) rpoB2 (2), parYR (47), tet(Q) (56), tet(32) (75), tet(O/W) (77), tet(W/32/O) (79), tet(W) (85), tet(O/W/O) (86), tet(W/N/W) (87), ABC transporter gene (157), aac(6')-aph(2'') (167), tet(40) (252), mefA (257), mef(En2) (267), cfxA6 (455), aad(6) (541), bifunctional aminoglycoside modifying enzyme gene (571), hygromycin-B kinase gene (526), aadE (658), isaE or putative spectomycin adenyltransferase gene (817), ermF (842), aphA3 (857), dam (919), sat4 (1160); Genus: Alistipes (G1), Anaeromassilibacillus (G2), Anaerotruncus (G3), Bacteroides (G4), Blautia (G5), Butyricicoccus (G6), Butyricimonas (G7), Chlamydia (G8), Cloacibacillus (G9), Clostridium (G10), Culturomica (G11), Desulfovibrio (G12), Escherichia (G13), Eubacterium (G14), Faecalibacterium (G15), Fibrobacter (G16), Flavonifractor (G17), Fusobacterium (G18), Intestinimonas (G19), Lachnoclostridium (G20), Lactobacillus (G21), Odoribacter (G22), Oscillibacter (G23), Parabacteroides (G24), Phascolarctobacterium (G25), Prevotella (G26), Pseudoflavonifractor (G27), Pyramidobacter (G28), Roseburia (G29), Sphaerochaeta (G30), Streptococcus (G31), Subdoligranulum (G32), Sutterella (G33), Treponema (G34), Veillonella (G35); Aminoglycoside resistance genes (B) aac(3) (A1), aac(6) (A2), aac(6) (A3), aac(6')-aph(2'') (A4), aacA4 (A5), aacC4 (A6), aad (A7), aadA15 (A8), aadA5 (A9), aadE (A10), aadE (A11), aadE (A12), aadK (A13), aadS (A14), acrD (A15), acrE (A16), acrF (A17), ant(6) (A18), ant(6) (A19), ant(9) (A20), aph(2) (A21), aph(2) (A22), aph(2) (A23), aph(3) (A24), envR (A25), hph (A26), kdpE (A27), neo (A28), npmA (A29), rmtF (A30), sat (A31), sat (A32), sph (A33), spw (A34), strA (A35), strB (A36); Multidrug resistance genes (C): acrA (M1), acrB (M2), baeS (M3), cmeA (M4), cmeB (M5), cmeC (M6), cpxA (M7), crp (M8), EB (M9), efrA (M10), emrA (M11), emrB (M12), emrK (M13), emrY (M14), evgA (M15), evgS (M16), gadW (M17), hns (M18), marA (M19), mdfA (M20), mdtA (M21), mdtB (M22), mdtC (M23), mdtE (M24), mdtF (M25), mdtG (M26), mdtH (M27), mdtK (M28), mdtM (M29), mef(En2) (M30), mefG (M31), mel (M32), mexF (M33), mprA (M34), msbA (M35), oqxB (M36), qacH (M37), smeB (M38), smeR (M39), taeA (M40), tlrC (M41), tolC (M42), yjcP (M43), yjcQ (M44), yjcR (M45), yojI (M46); Phenicol resistance genes (D): catB4 (P4), cml (P7), cmlA4 (P8), rlmN (P12); MLS resistance genes (E) ABC (m1), ABC (m2), ereD (m3), erm (m4), erm (m5), erm2 (m6), erm33 (m7), erm35 (m8), erm47 (m9), ermA (m10), ermFS (m11), ermM (m12), ermQ (m13), linG (m14), lnuB (m15), lnuC (m16), lsaE (m17), macB (m18), mefA (m19), mefA (m20), mefB (m21), mefE (m22), mphA (m23), mphB (m24), mphE (m25), oleB (m26), satG (m27), srmB (m28), tlrC (m29); Beta-lactam resistance genes (F) aci1 (B1), ampC (B2), ampH (B3), bla (B4), bla (B5), bla (B6), bla (B7), blaCARB (B8), blaLAP (B9), blaOXA (B10), blaOXA (B11), blaOXA (B12), blaTEM (B13), blaVEB (B14), cblA (B15), cepA (B16), cfxA5 (B17), cfxA6 (B18), fus-1 (B19), mrdA (B20), ompK37 (B21).
Programs of feeds, antibiotics and probiotics for pregnant sows and piglets.
| Feeds, antibiotics and probiotics | Day (Day 0 = Parturition day) |
|---|---|
| 400 ppm Chlortetracycline (dietary supplementation) | − 7 to − 6 |
| 100 ppm Tylvalosin (dietary supplementation) | − 7 to 7 |
| 10 mg/kg Kanamycin (intramuscular injection) | 1–3 |
| Probiotics (dietary supplementation)** | 1–3 |
| 15 mg/kg Amoxicillin (intramuscular injection) | 7 |
| Pre-starter feed | 7–32 |
| 2.5 mg/kg Turathromycin (intramuscular injection) | 21–23 |
400 ppm Amoxicillin and 250 ppm Neomycin (dietary supplementation) | 25–32 |
*Ad libitum chlorine in water (1 tablet/ 1000 L water) was allowed.
**Probiotics (Bactosac, K.M.P. Biotech, Chon Buri, Thailand): 109 colony-forming unit (CFU) each of B. subtilis, B. licheniformis, L. acidophilus, L. plantarum, Pediococcus pentosaceus and Sacchalomyces cerevisiae.